CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Blood samplesWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug1377 The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: Wiki 1.00

Correlated MeSH Terms (13)


Name (Synonyms) Correlation
D001997 Bronchopulmonary Dysplasia NIH 1.00
D008595 Menorrhagia NIH 1.00
D006470 Hemorrhage NIH 1.00
D006929 Hyperaldosteronism NIH 1.00
D014552 Urinary Tract Infections NIH 1.00
D000309 Adrenal Insufficiency NIH 1.00
D054559 Hyperphosphatemia NIH 1.00
D007008 Hypokalemia NIH 1.00
D006973 Hypertension NIH 0.35
D003141 Communicable Diseases NIH 0.10
D007239 Infection NIH 0.07
D045169 Severe Acute Respiratory Syndrome NIH 0.06
D018352 Coronavirus Infections NIH 0.05

Correlated HPO Terms (6)


Name (Synonyms) Correlation
HP:0000132 Menorrhagia HPO 1.00
HP:0002905 Hyperphosphatemia HPO 1.00
HP:0002900 Hypokalemia HPO 1.00
HP:0000846 Adrenal insufficiency HPO 1.00
HP:0000859 Hyperaldosteronism HPO 1.00
HP:0000822 Hypertension HPO 0.38

There is one clinical trial.

Clinical Trials


1 Study of INFLAmmasome NLRP3 and PLAtelets Functions During Severe COVID-19 Infection

COVID-19 pandemic is a severe viral sepsis characterized by the occurrence of Acute respiratory distress syndrome (ARDS) whose pathophysiology is little described

NCT04397822 COVID-19 Biological: Blood samples

Primary Outcomes

Description: Caspase-1 activity analyzed in patients in intensive care unit and in patients in standard care unit.

Measure: Activation of platelet NLRP3 inflammasome

Time: Day 0 During resuscitation (Covid-19 Resuscitation) or hospitalization (Covid-19 No Resuscitation)

Description: Labeling NOD-like receptor protein 3 (NLRP3)/Adaptor protein aptotosis-associated speck-like protein containing a CARD (ASC) analyzed in patients in intensive care unit and in patients in standard care unit.

Measure: Activation of platelet NLRP3 inflammasome

Time: During Day 0 During resuscitation (Covid-19 Resuscitation) or hospitalization (Covid-19 No Resuscitation)


No related HPO nodes (Using clinical trials)